Filter
4870
Filtered Results: 4870
Text search:
Drug
research
Featured
Recommendations
398
New Publications
1275
Language
Document type
No document type
3028
Studies & Reports
791
Guidelines
556
Manuals
178
Strategic & Response Plan
141
Fact sheets
70
Training Material
50
Situation Updates
19
Infographics
13
Brochures
10
Resource Platforms
9
Online Courses
3
App
1
Videos
1
Countries / Regions
India
272
Global
156
Kenya
154
Western and Central Europe
111
Ethiopia
110
Uganda
108
South Africa
106
Nigeria
103
Nepal
90
Liberia
79
Malawi
79
Africa
78
Zambia
76
Sierra Leone
73
Tanzania
73
Myanmar / Burma
66
Latin America and the Carribbean
66
Ghana
65
Bangladesh
61
Ukraine
57
Eastern Europe
56
Rwanda
52
Philippines
43
Russia
43
Asia
40
Zimbabwe
39
Namibia
37
Cambodia
36
South–East Asia Region
33
Lesotho
32
Indonesia
30
Mozambique
24
Congo, Democratic Republic of
23
Brazil
23
Botswana
22
Senegal
21
Syria
20
Germany
18
East and Southern Africa
18
Burkina Faso
17
Eswatini/ Swaziland
17
South Sudan
16
Colombia
16
West and Central Africa
16
Middle East and North Africa
15
Tajikistan
15
USA
14
Cameroon
13
Haiti
12
Pakistan
11
Thailand
11
Eastern Europe and Central Asia
11
Albania
11
Sudan
10
Argentina
10
Georgia
10
Guinea
9
China
9
Vietnam
9
Afghanistan
8
Venezuela
8
North Macedonia
7
Armenia
7
Laos
7
Moldova
7
Benin
6
Iraq
5
Peru
5
Mexico
5
Sri Lanka
5
Yemen
5
Western Pacific Region
5
Jordan
4
Lebanon
4
Central African Republic
4
Angola
4
Southern Africa
4
United Kingdom
4
Guinea-Bissau
3
Somalia
3
Turkey
3
Papua New Guinea
3
Serbia
3
Libya
3
Chile
3
Paraguay
3
Bhutan
3
Timor Leste/ East Timor
3
Iran
3
Kyrgyzstan
3
Jamaica
3
Belarus
3
Mali
2
Morocco
2
Saudi Arabia
2
Hungary
2
Ecuador
2
El Salvador
2
Poland
2
Palestine
2
Canada
2
Estonia
2
Kazakhstan
2
North America
2
Belgium
2
Portugal
2
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Chad
1
Gambia
1
Ireland
1
Singapore
1
Honduras
1
Bolivia
1
Greece
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Romania
1
Uzbekistan
1
Australia
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1805
Clinical Guidelines
435
Public Health
246
Women & Child Health
182
Key Resources
85
Pharmacy & Technologies
64
Capacity Building
59
Annual Report MEDBOX
1
Toolboxes
HIV
578
Mental Health
565
TB
497
AMR
267
COVID-19
211
NTDs
180
Pharmacy
126
NCDs
103
Caregiver
81
Ebola
78
Planetary Health
76
Rapid Response
73
Disability
56
Refugee
54
Global Health Education
53
Conflict
45
Health Financing Toolbox
30
Polio
19
Natural Hazards
16
Zika
15
Specific Hazards
15
Social Ethics
12
Cholera
10
Health Financing
1
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (GMS) has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response,...
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode...
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients w...
Rev Panam Salud Publica 45, 2021 |
Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r...
Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
